CureChat
AI-driven Solutions for Chronic Disease Management
StartupCureChat is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2023. AI-driven Solutions for Chronic Disease Management. CureChat was founded by Shimon Zilbershlag. The company has 1-10 employees. Core technologies: Artificial Intelligence, Chatbots.
The company follows a B2C business model. Product stage: Released.
- StagePre-Funding
- ProductReleased
- ModelB2C
- Employees1-10
- HQPetah Tikva
- DistrictCenter District
- Last RoundUndisclosed
Shimon ZilbershlagFounder & CEO
1 article covered by sources including www.robertplank.com.
What does CureChat do?
CureChat is a digital health company specializing in AI-driven solutions for chronic disease management. Its flagship product, Dana, is an AI-powered diabetes assistant that provides free, personalized, and medically accurate support based on ADA guidelines. CureChat focuses on improving diabetes education and accessibility, particularly in emerging markets, while ensuring privacy and compliance with healthcare standards.
Who founded CureChat?
CureChat was founded in 2023 by Shimon Zilbershlag (Founder & CEO).
What sector is CureChat in?
CureChat operates in Health Tech & Life Sciences, Digital Healthcare, Patient Engagement, with core technologies in Artificial Intelligence, Chatbots. Target customers: Healthcare & Life Sciences, Healthcare, Patients.
Where is CureChat located?
CureChat is based in Zelig Bas St 7, Petah Tikva, Israel, Center District.